WDA
IDXX icon

Wendell David Associates’s Idexx Laboratories IDXX Stock Holding History

Wendell David Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.98M Buy
11,363
+295
+3% +$165K 0.63% 37
2026
Q1 		$6.22M Sell
11,068
-1,245
-10% -$798K 0.68% 35
2025
Q4 		$8.33M Sell
12,313
-808
-6% -$550K 0.85% 30
2025
Q3 		$8.38M Sell
13,121
-31
-0.2% -$18.8K 0.83% 32
2025
Q2 		$7.05M Sell
13,152
-20
-0.2% -$9.56K 0.71% 37
2025
Q1 		$5.53M Sell
13,172
-917
-7% -$398K 0.55% 40
2024
Q4 		$5.83M Sell
14,089
-3,163
-18% -$1.39M 0.58% 41
2024
Q3 		$8.72M Sell
17,252
-1,497
-8% -$727K 0.83% 35
2024
Q2 		$9.13M Buy
18,749
+70
+0.4% +$35.1K 0.93% 32
2024
Q1 		$10.1M Sell
18,679
-395
-2% -$216K 1.02% 31
2023
Q4 		$10.6M Sell
19,074
-72
-0.4% -$33.8K 1.14% 29
2023
Q3 		$8.37M Buy
19,146
+445
+2% +$222K 0.99% 31
2023
Q2 		$9.39M Sell
18,701
-205
-1% -$98.2K 1.06% 28
2023
Q1 		$9.46M Sell
18,906
-57
-0.3% -$27.3K 1.12% 30
2022
Q4 		$7.74M Sell
18,963
-398
-2% -$154K 0.95% 31
2022
Q3 		$6.31M Sell
19,361
-685
-3% -$252K 0.85% 33
2022
Q2 		$7.03M Sell
20,046
-713
-3% -$291K 0.89% 34
2022
Q1 		$11.4M Sell
20,759
-1,030
-5% -$542K 1.26% 27
2021
Q4 		$14.3M Sell
21,789
-933
-4% -$586K 1.45% 23
2021
Q3 		$14.1M Sell
22,722
-1,165
-5% -$783K 1.58% 20
2021
Q2 		$15.1M Sell
23,887
-605
-2% -$334K 1.69% 20
2021
Q1 		$12M Sell
24,492
-730
-3% -$366K 1.44% 21
2020
Q4 		$12.6M Sell
25,222
-180
-0.7% -$80.5K 1.54% 20
2020
Q3 		$9.99M Sell
25,402
-140
-0.5% -$51.8K 1.33% 22
2020
Q2 		$8.43M Sell
25,542
-1,125
-4% -$326K 1.22% 28
2020
Q1 		$6.46M Sell
26,667
-270
-1% -$70.5K 1.09% 30
2019
Q4 		$7.03M Buy
26,937
+7
+0% +$1.84K 0.97% 34
2019
Q3 		$7.32M Sell
26,930
-850
-3% -$237K 1.07% 30
2019
Q2 		$7.65M Sell
27,780
-275
-1% -$67.8K 1.15% 29
2019
Q1 		$6.27M Sell
28,055
-1,335
-5% -$276K 0.98% 33
2018
Q4 		$5.47M Sell
29,390
-981
-3% -$201K 0.98% 32
2018
Q3 		$7.58M Sell
30,371
-827
-3% -$201K 1.18% 27
2018
Q2 		$6.8M Buy
31,198
+1,150
+4% +$237K 1.16% 27
2018
Q1 		$5.75M Sell
30,048
-5,413
-15% -$999K 1.04% 34
2017
Q4 		$5.54M Sell
35,461
-531
-1% -$83.6K 0.95% 36
2017
Q3 		$5.6M Sell
35,992
-1,524
-4% -$241K 0.99% 32
2017
Q2 		$6.06M Sell
37,516
-3,475
-8% -$564K 1.14% 26
2017
Q1 		$6.34M Sell
40,991
-9,315
-19% -$1.28M 1.21% 26
2016
Q4 		$5.9M Sell
50,306
-3,000
-6% -$342K 1.16% 26
2016
Q3 		$6.01M Sell
53,306
-470
-0.9% -$49.5K 1.19% 26
2016
Q2 		$5M Sell
53,776
-2,160
-4% -$185K 0.98% 30
2016
Q1 		$4.36M Buy
55,936
+12
+0% +$864 0.85% 34
2015
Q4 		$4.08M Buy
55,924
+3,589
+7% +$256K 0.81% 36
2015
Q3 		$3.87M Buy
52,335
+3,555
+7% +$255K 0.8% 38
2015
Q2 		$3.12M Buy
48,780
+13,770
+39% +$953K 0.61% 47
2015
Q1 		$2.7M Hold
35,010
– – 0.52% 49
2014
Q4 		$2.59M Buy
35,010
+100
+0.3% +$7.01K 0.51% 52
2014
Q3 		$2.06M Buy
34,910
+150
+0.4% +$9.48K 0.43% 56
2014
Q2 		$2.33M Buy
34,760
+50
+0.1% +$3.18K 0.49% 54
2014
Q1 		$2.1M Sell
34,710
-100
-0.3% -$5.96K 0.46% 55
2013
Q4 		$1.84M Sell
34,810
-100
-0.3% -$5.26K 0.4% 62
2013
Q3 		$1.75M Buy
34,910
+1,350
+4% +$64.9K 0.42% 59
2013
Q2 		$1.51M Buy
+33,560
New +$1.47M 0.38% 63

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Wendell David Associates's IDXX Position: Q2 2026 in Review

Wendell David Associates increased its Idexx Laboratories (IDXX) stake by 2.7% in Q2 2026, buying an estimated $165K and bringing the position to 11,363 shares worth $5.98M. The position accounts for 0.63% of the portfolio, ranked #37.

Wendell David Associates first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.1M in Q2 2021. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Wendell David Associates held 11,363 shares of Idexx Laboratories worth $5.98M as of Q2 2026.
  • Wendell David Associates bought 295 Idexx Laboratories shares in Q2 2026, an estimated $165K.
  • Idexx Laboratories made up 0.63% of Wendell David Associates's portfolio in Q2 2026, its #37 holding.
  • Wendell David Associates first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Wendell David Associates's Idexx Laboratories position peaked at $15.1M in Q2 2021.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.